Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Finasteride can cause enlarged breasts.

Finasteride does not prevent bladder cancer.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride use may be linked to rare testicular tumor, but more research needed.

Finasteride treats baldness but may cause lasting sexual side effects.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Finasteride use can cause depression-like behavior in male rats.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Finasteride overdose can cause acute pancreatitis.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Early hair loss may indicate prostate issues.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.